Cardiac Arrest Study Hamburg - CASH


The Cardiac Arrest Study Hamburg (CASH) trial was designed to compare survival with antiarrhythmic drugs—propafenone, amiodarone, or metoprolol—versus implantable cardioverter defibrillators (ICDs) in survivors of cardiac arrest due to documented ventricular arrhythmias. The trial began in 1987 when ICDs were implanted via thoracotomy, and were still considered investigational devices.